Abstract:Abstract Understanding the tumor microenvironment and detecting rare circulating tumor cells from blood are two major challenges faced by cancer biologists and oncologists. Both require high sensitivity and accuracy in classifying and isolating single cells in a complex and heterogeneous environment. Classical cell classification and sorting techniques are limited by their reliance on pre-selected cell biomarkers or physical characteristics. Recent breakthroughs in machine learning have achieved unprecedented accuracy across a wide range of image classification problems. We have developed a platform that combines high-resolution imaging of unlabeled cells in microfluidic flow with real-time deep neural network (DNN) based classification and sorting. The DNN classifier was trained on more than 25 million high-resolution cell images of multiple types imaged on the platform. Our model was trained to discriminate among multiple cell classes, including immune cell subtypes, non-small-cell lung cancer cells (NSCLC), hepatocellular carcinomas (HCC), and stromal cells (including endothelial, epithelial, fibroblasts, smooth muscle cells). We then assessed model performance on a separate validation set of cell images, including cell lines not used in the training data. Our classifier accurately identifies NSCLC and HCC against a background of blood cells with an area under the ROC curve (AUC) of > 0.999. In addition we demonstrate the enrichment of NSCLC cells from spike-in mixtures with WBCs or whole blood at concentrations as low as 1:100,000, achieving an enrichment of > 25,000x on multiple cell lines. Using dissociated lung cancer tissue, we demonstrate that our label-free classification of tumor cells closely matches results from both standard flow cytometer analysis and single cell RNA sequencing. Additionally we were able to enrich the tumor cell fraction from dissociated tumor tissue thereby improving the sensitivity of mutation detection and enabling refined downstream single-cell genomic analysis. This work demonstrates that deep learning using high-resolution cell images collected at scale can achieve a high classification accuracy and can enable the label-free isolation of rare cells of interest for a wide range of applications. This system can be used to analyze tumor biopsies and liquid biopsies and has the potential to enable the study of tumor cells and tumor microenvironment with novel dimension and insight. Citation Format: Mahyar Salek, Hou-pu Chou, Prashast Khandelwal, Krishna P. Pant, Thomas J. Musci, Nianzhen Li, Christina Chang, Andreja Jovic, Esther Lee, Stephanie Huang, Jeff Walker, Phuc Nguyen, Kiran Saini, Jeanette Mei, Quillan F. Smith, Maddison Masaeli. Deep learning enables label-free profiling of the tumor microenvironment and enrichment of rare cancer cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 188.

Machine Learning-Assisted CellIdentification Based on Ion CurrentFingerprints of Single Cells at Theorifice of a Nanopipette

Machine Learning for Identification of Cancer Cells Based on Electrical Property Using Microfluidic Impedance Flow Cytometry

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

Machine learning classification of cellular states based on the impedance features derived from microfluidic single-cell impedance flow cytometry

Development of Microfluidic Platform to High-Throughput Quantify Single-Cell Intrinsic Bioelectrical Markers of Tumor Cell Lines, Subtypes and Patient Tumor Cells

Label-free liquid biopsy through the identification of tumor cells by machine learning-powered tomographic phase imaging flow cytometry

Single-Cell Classification Based on Population Nucleus Size Combining Microwave Impedance Spectroscopy and Machine Learning

Validation of a Microfluidic Device Prototype for Cancer Detection and Identification: Circulating Tumor Cells Classification Based on Cell Trajectory Analysis Leveraging Cell-Based Modeling and Machine Learning

Label-Free Resistance Cytometry at the Orifice of a Nanopipette.

Laser tweezer Raman spectroscopy combined with deep neural networks for identification of liver cancer cells

A New Method for CTC Images Recognition Based on Machine Learning

Abstract 188: Deep learning enables label-free profiling of the tumor microenvironment and enrichment of rare cancer cells

Genetic and Phenotypic Profiling of Single Living Circulating Tumor Cells from Patients with Microfluidics

Fully Automated CTC Detection, Segmentation and Classification for Multi-Channel IF Imaging

Machine Learning Assisted Spectral Fingerprinting for Immune Cell Phenotyping

Computer-Vision-Based Dielectrophoresis Mobility Tracking for Characterization of Single-Cell Biophysical Properties.

Microfluidics-based patient-derived disease detection tool for deep learning-assisted precision medicine

All-in-One Microfluidic Chip for Online Labeling, Separating, and Focusing Rare Circulating Tumor Cells from Blood Samples Followed by Inductively Coupled Plasma Mass Spectrometry Detection

DNA-Oriented Shaping of Cell Features for the Detection of Rare Disseminated Tumor Cells

Single-Cell Codetection of Metabolic Activity, Intracellular Functional Proteins, and Genetic Mutations from Rare Circulating Tumor Cells